Fig. 3From: Development and validation of a nomogram based on biparametric MRI PI-RADS v2.1 and clinical parameters to avoid unnecessary prostate biopsiesReceiver operating characteristic curves of risk prediction models for clinically significant prostate cancer in all cohorts. A Diagnosis of csPCa in the development cohort. B Diagnosis of csPCa in validation cohort 1. C Diagnosis of csPCa in validation cohort 2. csPCa = Clinically significant prostate cancerBack to article page